Folia Pharmacologica Japonica
Online ISSN : 1347-8397
Print ISSN : 0015-5691
ISSN-L : 0015-5691
Review on New Drug
Preclinical and clinical researches of lenvatinib mesylate (Lenvima capsule), a novel antitumor agent approved for thyroid cancer treatment
Akihiko TsuruokaJunji MatsuiTakuya SuzukiNoriyuki KoyamaTatsuo WatanabeYasuhiro Funahashi
Author information
JOURNAL FREE ACCESS

2015 Volume 146 Issue 5 Pages 283-290

Details
Abstract

[in Japanese]

Content from these authors
© 2015 by The Japanese Pharmacological Society
Previous article
feedback
Top